This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $538.22 in the latest trading session, marking a -1.4% move from the prior day.
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Humana (HUM) Rises 23% in Past 6 Months: More Room to Run?
by Zacks Equity Research
Humana (HUM) is well-poised for growth on improving revenues, numerous contract wins and adequate cash-generating abilities.
Acadia (ACHC) Reveals its Long-Term Goals: What You Should Know
by Zacks Equity Research
From 2022 to 2028, Acadia Healthcare (ACHC) expects to see a 9-11% CAGR in revenues.
Is SPDR MSCI USA StrategicFactors ETF (QUS) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for QUS
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $542.91, marking a +0.67% move from the previous day.
Centene (CNC) Invests Nearly $8M to Build Texas Community Center
by Zacks Equity Research
Centene (CNC) collaborates with CHDI to establish a new community center in Texas, reflecting efforts to expand its Managed Care business across the state.
4 Defensive Stocks to Prepare Your Portfolio for a Recession
by Anirudha Bhagat
Amid the rising possibility of a recession, defensive stocks with solid prospects will cushion investors from market jitters while their robust fundamentals ensure higher returns. ADM, HSY, UNH and MRK are some such stocks.
The Joint (JYNT) Expands Operations to Alaska With 3 Clinics
by Zacks Equity Research
The Joint's (JYNT) expansionary move is expected to be a prudent one, given the growing demand for affordable and convenient chiropractic care in the region.
Is Vanguard Dividend Appreciation ETF (VIG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for VIG
Centene (CNC) Concludes Magellan Rx Divestment to Prime
by Zacks Equity Research
Centene (CNC) completes Magellan Rx divestment within the scheduled time.
The Zacks Analyst Blog Highlights UnitedHealth Group, Blackstone, Cigna, Canadian National Railway and PG&E
by Zacks Equity Research
UnitedHealth Group, Blackstone, Cigna, Canadian National Railway and PG&E are included in this Analyst Blog.
Zacks Investment Ideas feature highlights: Petroleo Brasileiro, Cboe Global Markets and UnitedHealth
by Zacks Equity Research
Petroleo Brasileiro, Cboe Global Markets and UnitedHealth have been highlighted in this Investment Ideas article.
3 Top-Ranked Companies With Supercharged Dividend Growth
by Derek Lewis
On top of strong dividend growth, all three stocks have displayed remarkable relative strength in 2022, outperforming the general market handily.
Top Analyst Reports for UnitedHealth, Blackstone & Cigna
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Blackstone Inc. (BX) and Cigna Corporation (CI).
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The Zacks Analyst Blog Highlights Caterpillar, Merck, UnitedHealth Group and Walmart
by Zacks Equity Research
Caterpillar, Merck, UnitedHealth Group and Walmart are included in this Analyst Blog.
Top 4 Blue-Chip Stocks to Enhance Your Portfolio in December
by Nalak Das
We have narrowed our search to four Dow stocks. These are: CAT, WMT, MRK, UNH.
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $536.91 in the latest trading session, marking a -1.98% move from the prior day.
Can High Income ETFs Stay Hot in 2023?
by Neena Mishra
Here are some interesting strategies for income investors.
Wall Street Analysts Look Bullish on UnitedHealth (UNH): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in UnitedHealth (UNH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Should Vanguard Value ETF (VTV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VTV
2 High Income ETFs Crushing the S&P 500
by Neena Mishra
These ETFs use option strategies to generate juicy income & lower portfolio volatility
What You Need to Know From UnitedHealth's (UNH) Latest Outlook
by Zacks Equity Research
UnitedHealth (UNH) expects the top line to be within the range of $357-$360 billion in 2023.